bioAffinity Technologies, Inc. Logo

bioAffinity Technologies, Inc.

Develops noninvasive diagnostics for cancer, including an early lung cancer sputum test.

BIAF | NDAQ

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
3300 NACOGDOCHES ROAD, 78217 SAN ANTONIO
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

bioAffinity Technologies, Inc. is a biotechnology company focused on developing noninvasive diagnostics and targeted therapeutics for cancer and other diseases. Its flagship product, CyPath® Lung, is a non-invasive test for the early detection of lung cancer. The test utilizes an automated flow cytometry platform to analyze patient sputum, employing a proprietary porphyrin-based technology that preferentially targets cancer cells. It is intended for use in high-risk individuals with indeterminate lung nodules identified through low-dose computed tomography (LDCT) to improve diagnostic accuracy. CyPath® Lung is offered as a Laboratory Developed Test (LDT) through the company's CLIA-certified subsidiary, Precision Pathology Laboratory Services. The company's research and development pipeline aims to expand its platform for other diagnostics, such as COPD, and to develop novel cancer therapies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all bioAffinity Technologies, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for bioAffinity Technologies, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for bioAffinity Technologies, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.